PharmaShots | Incisive News in 3 Shots

Subscribe Now

Madrigal

Madrigal Reports Results of Resmetirom in P-III (MAESTRO-NAFLD-1) Study for the Treatment of Non-Alcoholic Steatohepatitis

Madrigal Reports Results of Resmetirom in P-III (MAESTRO-NAFLD-1) Study for the Treatment of Non-Alcoholic Steatohepatitis

February 1, 2022

Madrigal Provides Update in the P-III (MAESTRO-NAFLD-1) Trial of Resmetirom for the Treatment of Non-Alcoholic Steatohepatitis

Madrigal Provides Update in the P-III (MAESTRO-NAFLD-1) Trial of Resmetirom for the Treatment of Non-Alcoholic Steatohepatitis

December 31, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us